Catalent Inc (CTLT)
Open: 109.56 High: 111.02 Low: 109.19
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
Catalent Inc trades on the NYSE. CTLT's market cap is 18.6 Billion.
Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.